ResearcherRenmin Hospital of Wuhan UniversityNo recent work listed

Jing Tao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8947-7520; OpenAlex author ID A5102782822. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysis Last author DOI 10.21203/rs.3.rs-135235/v2 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pei Mei · 1 shared paper, 2021 · strength 0.14
- Paper The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysis DOI 10.21203/rs.3.rs-135235/v2 ↗
Zhi‐Gang Tang · 1 shared paper, 2021 · strength 0.14
- Paper The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysis DOI 10.21203/rs.3.rs-135235/v2 ↗
Hengqiang Zhao · 1 shared paper, 2021 · strength 0.14
- Paper The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysis DOI 10.21203/rs.3.rs-135235/v2 ↗
Zhengle Zhang · 1 shared paper, 2021 · strength 0.14
- Paper The reciprocal loop of MALAT1 and HIF-1α facilitates gemcitabine resistance in pancreatic cancer by enhancing glycolysis DOI 10.21203/rs.3.rs-135235/v2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.